Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts.
about
The fibrosis-cell death axis in heart failurePirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosisThe antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis.Overexpression of SerpinE2/protease nexin-1 Contribute to Pathological Cardiac Fibrosis via increasing Collagen Deposition.Pirfenidone for the treatment of idiopathic pulmonary fibrosis.The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.Mitochondria Associated MicroRNA Expression Profiling of Heart Failure.Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury.Assessment of cardiac fibrosis: a morphometric method comparison for collagen quantification.A new low nephron-CKD model with hypertension, progressive decline of renal function and enhanced inflammation in C57BL/6 mice.Pirfenidone exerts a suppressive effect on CCL18 expression in U937-derived macrophages partly by inhibiting STAT6 phosphorylation.A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model.
P2860
Q28076570-0A20724F-E6E8-4FFA-A458-09DB6B5FCCC8Q28468333-1D58FF4B-0F55-4B67-95EE-C1878248AC89Q37277346-113CC867-5BCE-4F11-BCBF-AB99C62057F5Q37431141-CC87CAC9-AF69-4010-9957-A2D8DC9A7FFAQ39165575-C60D5634-F4D6-4CAD-889A-D698096B7EC8Q42694416-B01D17F1-F8AA-4644-B8E0-38787F19910CQ47152797-02CEC9F8-C35A-4B1B-8DE1-15DD8C5D8BAEQ47990145-D4A12AEB-7959-4524-B9EA-51B662FFF728Q47994656-DA062269-C00D-404D-B885-5ECAED11B2E0Q50141004-B3552092-F58A-45D8-8FFE-C0D929DB4AEFQ51359224-C5838E89-1293-4E02-9BEF-A9ED3A5FB0A2Q54958024-5BB18467-745E-4EFD-9106-57D74E4D76AE
P2860
Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@en
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@nl
type
label
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@en
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@nl
prefLabel
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@en
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@nl
P2093
P2860
P1476
Pirfenidone exhibits cardiopro ...... in pressure-overloaded hearts.
@en
P2093
Atsuhiko T Naito
Hiroshi Akazawa
Jong-Kook Lee
Keiko Miwa
Kiyoshi Yamagami
Takamaru Ishizu
Yasushi Sakata
P2860
P304
P356
10.1152/AJPHEART.00137.2015
P50
P577
2015-06-08T00:00:00Z